drugset
drugset / Trial / NCT05020496

Trem-1 and Ultraviolet Radiation-induced Immune Suppression

NCT05020496 ↗

Phase 0 Active not recruiting 70 enrolled University of Alabama at Birmingham
RandomizedSingle-groupOpen-labelBasic science

Summary

The overall goal of this study is to determine novel mechanisms for ultraviolet light (UV)-induced suppression of the immune system in human subjects and to improve understanding of UV-induced skin carcinogenesis.

Timeline

Start
2022-03-21
Primary completion
2027-06-30
Completion
2027-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Diphencyprone Small molecule — Topical

Indications

skin disorder